Our Partners
Partnership is how SCRI's work gets done. As Singapore's national academic clinical research organisation and national coordinating body for clinical trials, we sit where researchers, regulators, healthcare institutions, industry sponsors and patients meet.
Partnership is how SCRI's work gets done. As Singapore's national academic clinical research organisation and national coordinating body for clinical trials, we sit where researchers, regulators, healthcare institutions, industry sponsors and patients meet. Some of our closest collaborators bridge the public and private domains — a dual perspective we value. What unites every partnership is a shared purpose: bringing well-designed, well-run trials to the patients who stand to benefit.
Public sector partnerships
These anchor our work in Singapore's national health and research priorities, spanning regulation, clinical delivery, scientific research and economic development.
Health Sciences Authority (HSA) — regulatory pathways and standards
NHG Health, NUHS and SingHealth — our three public healthcare clusters, whose investigators and clinical trial units make real-world research possible
Economic Development Board (EDB) and Enterprise Singapore (EnterpriseSG) — growing Singapore's clinical research industry
NUS, NTU and Duke-NUS Medical School — scientific collaboration and capability-building
A*STAR — national research agency partnerships across the translational pipeline
Our July 2026 five-year MOU on Catalysing Clinical Trials Excellence brings several of these partners together, with SCRI and HSA jointly establishing an integrated clinical trial concierge service — a single coordinated entry point for sponsors navigating Singapore's research and regulatory landscape.
Private sector partnerships
These bring new therapies within reach of patients here and across the region.
AstraZeneca — early- and late-phase trials of novel modalities, including antibody-drug conjugates, cell and gene therapies and bispecific antibodies
Pharmaceutical, biotechnology and medical technology sponsors — trial delivery across our therapeutic areas
Contract research organisations — operational collaboration and shared standards
Singapore Association of Pharmaceutical Industries (SAPI) and the Singapore Clinical Research Professionals Association (SCRP) — sector bodies with whom we raise standards across the community
Temasek Foundation — philanthropic support for regional capability-building in epidemic preparedness
If you are considering Singapore as a trial destination, our Business Development team would be glad to be your first point of contact.